The different driving factors for the insulin pumps market include the growing prevalence of chronic diseases (requiring real-time monitoring), shift towards decentralized trials (eliminating need for frequent in-person visits by the patient) and increasing adoption of smart digital devices. Our estimates suggest that, presently, in terms of type of pump, majority share of the insulin pumps market is captured by patch pumps; this can be attributed to the fact that they can be conveniently operated wirelessly by a separate device to monitor blood sugar levels continuously throughout the day and allow automatic delivery of insulin after meals.

The insulin pump market size is projected to grow from $ 5.8 billion in 2024 to $ 13.6 billion by 2035, representing a CAGR of 8% during the forecast period till 2035.

It is worth mentioning that, in 2035, rechargeable batteries are likely to dominate the insulin pumps market.

Further, currently, the maximum revenue generated in this domain is likely to be driven by insulin pumps targeting Type 1 diabetes and this trend (in terms of market size) is unlikely to change in the future as well. Notably, the insulin pumps market is anticipated to grow at a higher pace, having a CAGR of 8%, during the forecast period. Moreover, in 2024, retail pharmacies capture around 50% share of the overall market, followed by the market share captured by online pharmacies (23%).

Increase in the Intellectual Capital- An Evidence for Progression in R&D Activity for Insulin Pumps

Over 1,600 patents related to insulin pumps have been filed / granted, indicating the heightened pace of innovation in this domain. Notably, around 35% of the patents were published in 2022, followed by those published in 2023 (31%). Further, most (~55%) of the patents in this domain were patent applications (not having received approval yet).

Despite the large number of patents that have been filed recently (and hence having a long remaining patent life), only 1% of the total patents filed in this domain have a significantly higher relative valuation. This is primarily because of the relatively low citations of the patents that have been filed recently, leading to low patent value. It is worth mentioning that Medtronic leads in insulin pump patent filings, demonstrating its strong commitment to advancing glucose management through designing of innovative pumps.

Insulin Pumps: Bridging The Gap to Improve Diabetes Control

In recent decades, the prevalence of diabetes has risen dramatically worldwide; it is worth mentioning that diabetes affects more than 420 million people globally. The conventional treatment approaches for diabetes management include lifestyle changes, oral therapeutics and insulin injections; however, these approaches have certain drawbacks such as painful and inconvenient procedures that often result in poor medication adherence. As a result, advanced insulin delivery systems, particularly insulin pumps, are increasingly being adopted as a sophisticated and patient-friendly solution. These devices are small, light-weight and deliver insulin either continuously or in controlled intervals, tailored to the patient's needs.

The insulin pumps sector has several significant megatrends that shape its development and adoption, including rising popularity of patch pumps, integration with continuous glucose monitors (for automated insulin delivery), enhanced interoperability via smartphones and cloud-based systems (for data tracking and sharing with doctors / physicians), and employment of artificial intelligence and machine learning (for improved insulin dosing algorithms).

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/insulin-pump-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/